Premium Information is available for this item - Upgrade for $1 a day
6505-01-135-8461
Theophylline Extended-Release Tablets
6505011358461 011358461 CONSTANT-T NDC00028-0057-73
INC: 42612 Theophylline Extended-Release Tablets
January 2023
4
Marketplace 6505-01-135-8461
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-135-8461 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-135-8461 RQST Updated Every Day 6505-01-135-8461 RQST NE Related Documents
6505-01-135-8461 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-135-8461
01-201-0809 fsg-65/fsc-6505/us 6505-01-268-7538 Theophylline Extended-Release Tablets 011353174 CONSTANT-T
fsg-65/fsc-6505/uk 6505-99-212-8295 Theophylline https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-135-8461
Theophylline Extended-Release Tablets us 6505-01-201-0809 Theophylline Extended-Release Tablets 011358461
Extended-Release Tablets 6505-01-135-3174 6505-01-073-1552 6505-15-188-4482 https/ /fsc-6505/us 6505-01-135-8461
Theophylline Extended-Release Tablets 4482 https/ Extended-Release Tablets CONSTANT-T https//www.nsnlookup.com
201-0809 6505-01-268-7538 6505-01-135-3174 6505-01-073-1552 6505-15-188-4482 6505-01-083-6613 6505-01-135-8461
www.nsnlookup.com 268-7538 6505-01-135-3174 6505-01-073-1552 6505-15-188-4482 6505-01-083-6613 6505-01-135-8461
Tablets Theophylline Extended-Release Tablets UNIPHYL Theophylline Extended-Release Tablets 6505-01-135-8461
Restrictions 6505-01-135-8461
6505-01-135-8461 is a Theophylline Extended-Release Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-135-8461
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-135-8461
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-135-8461
- Part Number
- Manufacturer
- Status
- NDC00028-0057-73
- Manufacturer
- 97423 - Ciba-Geigy Corp (Active)
- Primary Buy
- Primary Buy
- CONSTANT-T
- 97423 - Ciba-Geigy Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-135-8461
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 300.000 Milligrams Theophylline, Anhydrous Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 60.000 Tablets
- Special Features [FEAT]
- Child Resistant Closure And 3 Part Label;Long Action Method:Extended Release;
Management Data 6505-01-135-8461
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Sep 1991
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 60 Tt
- 00000000060TT
- K
Similar Supply Items to 6505-01-135-8461
Freight Information 6505-01-135-8461
6505-01-135-8461 has freight characteristics.. 6505-01-135-8461 has a variance between NMFC and UFC when transported by rail and the description should be consulted.